Dividing T cells: A potential target for improving cancer immunotherapy
Friday, July 1, 2016 - 11:51
in Biology & Nature
When an immune T cell divides into two daughter cells, the activity of an enzyme called mTORC1, which controls protein production, splits unevenly between the progeny, producing two cells with different properties. Such “asymmetric division,” uncovered by Johns Hopkins Kimmel Cancer Center researchers using lab-grown cells and specially bred mice, could offer new ways to […]